Merck KGaA is expanding its production of organic light-emitting diodes (OLEDs) with a €20 million investment in Asia. Capacity additions are planned at sites in...
Germany’s Merck KGaA has agreed to collaborate with Mammoth Biosciences on development, scale-up and commercial production of the US biotech’s CRISPR-based SARS CoV-2...
The US Court of Appeals for the Federal Circuit on Sept. 28 set aside a decision of the US district court of New Jersey in Newark, reversing the district court’s earlier...
Under the name M Lab, Germany’s Merck has opened a new collaborative drug development center in Pudong, Shanghai, China. The facility with lab space of around 10,000 m2...
15.06.2020
- Merck KGaA has agreed a strategic partnership with US-based Guardian Glass to commission sales of its eyrise-branded dynamic liquid crystal windows. With the deal, the German...
03.06.2020
- In the latest round of the trademark battle between Merck & Co of the US (known outside North America as MSD) and Germany’s Merck KGaA (which trades in North America as EMD), the...
14.05.2020
- German pharmaceuticals and life sciences group Merck has won US approval for its CRISPR-Cas9-assisted genome-editing patents and now is looking to license the technology to US...
27.04.2020
- German pharmaceuticals, chemicals and Life Science group Merck has acquired Konica Minolta’s entire OLED patent portfolio for display applications for an undisclosed sum. The...